BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Andreone S, Gambardella AR, Mancini J, Loffredo S, Marcella S, La Sorsa V, Varricchi G, Schiavoni G, Mattei F. Anti-Tumorigenic Activities of IL-33: A Mechanistic Insight. Front Immunol 2020;11:571593. [PMID: 33329534 DOI: 10.3389/fimmu.2020.571593] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Huang F, Chen WY, Ma J, He XL, Wang JW. Paradoxical role of interleukin-33/suppressor of tumorigenicity 2 in colorectal carcinogenesis: Progress and therapeutic potential. World J Clin Cases 2022; 10(1): 23-34 [DOI: 10.12998/wjcc.v10.i1.23] [Reference Citation Analysis]
2 Jiang J, Zhang F, Wan Y, Fang K, Yan ZD, Ren XL, Zhang R. Semaphorins as Potential Immune Therapeutic Targets for Cancer. Front Oncol 2022;12:793805. [PMID: 35155237 DOI: 10.3389/fonc.2022.793805] [Reference Citation Analysis]
3 Lei S, Jin J, Zhao X, Zhou L, Qi G, Yang J. The role of IL-33/ST2 signaling in the tumor microenvironment and Treg immunotherapy. Exp Biol Med (Maywood) 2022;:15353702221102094. [PMID: 35733343 DOI: 10.1177/15353702221102094] [Reference Citation Analysis]
4 Ring SS, Cupovic J, Onder L, Lütge M, Perez-Shibayama C, Gil-Cruz C, Scandella E, De Martin A, Mörbe U, Hartmann F, Wenger R, Spiegl M, Besse A, Bonilla WV, Stemeseder F, Schmidt S, Orlinger KK, Krebs P, Ludewig B, Flatz L. Viral vector-mediated reprogramming of the fibroblastic tumor stroma sustains curative melanoma treatment. Nat Commun 2021;12:4734. [PMID: 34354077 DOI: 10.1038/s41467-021-25057-w] [Reference Citation Analysis]
5 Rasheed K, Moens U, Policastro B, Johnsen JI, Koljonen V, Sihto H, Lui WO, Sveinbjørnsson B. The Merkel Cell Polyomavirus T-Antigens and IL-33/ST2-IL1RAcP Axis: Possible Role in Merkel Cell Carcinoma. Int J Mol Sci 2022;23:3702. [PMID: 35409061 DOI: 10.3390/ijms23073702] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ikutani M, Nakae S. Heterogeneity of Group 2 Innate Lymphoid Cells Defines Their Pleiotropic Roles in Cancer, Obesity, and Cardiovascular Diseases. Front Immunol 2022;13:939378. [DOI: 10.3389/fimmu.2022.939378] [Reference Citation Analysis]
7 Akcora-Yildiz D, Yukselten Y, Sunguroglu M, Ugur HC, Sunguroglu A. IL-33 induces ADAMTS5 expression and cell migration in glioblastoma multiforme. Med Oncol 2022;39:22. [PMID: 34982269 DOI: 10.1007/s12032-021-01590-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Mun JY, Leem SH, Lee JH, Kim HS. Dual Relationship Between Stromal Cells and Immune Cells in the Tumor Microenvironment. Front Immunol 2022;13:864739. [PMID: 35464435 DOI: 10.3389/fimmu.2022.864739] [Reference Citation Analysis]
9 Di Gioacchino M, Della Valle L, Allegra A, Pioggia G, Gangemi S. AllergoOncology: Role of immune cells and immune proteins. Clin Transl Allergy 2022;12:e12133. [PMID: 35344301 DOI: 10.1002/clt2.12133] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Zhang Y, Li J, Yang F, Zhang X, Ren X, Wei F. Relationship and prognostic significance of IL-33, PD-1/PD-L1, and tertiary lymphoid structures in cervical cancer. J Leukoc Biol 2022. [PMID: 35501298 DOI: 10.1002/JLB.5MA0322-746R] [Reference Citation Analysis]